Pharmacokinetics of new oral hepatitis C antiviral drugs
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Expert opinion on drug metabolism & toxicology - 9(2013), 1 vom: Jan., Seite 5-16 |
| Beteiligte Personen: |
Vispo, Eugenia [VerfasserIn] |
|---|
| Umfang: |
12 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1908992409 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1908992409 | ||
| 003 | DE-627 | ||
| 005 | 20230511221100.0 | ||
| 007 | tu | ||
| 008 | 121217s2013 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw121215_1 |
| 035 | |a (DE-627)OLC1908992409 | ||
| 035 | |a (DE-599)GBVOLC1908992409 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 100 | 1 | |a Vispo, Eugenia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacokinetics of new oral hepatitis C antiviral drugs |
| 264 | 1 | |c 2013 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Barreiro, Pablo |4 oth | |
| 700 | 1 | |a Soriano, Vicente |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on drug metabolism & toxicology |d London : Informa Healthcare, 2005 |g 9(2013), 1 vom: Jan., Seite 5-16 |w (DE-627)504864742 |w (DE-600)2214462-6 |x 1742-5255 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2013 |g number:1 |g month:01 |g pages:5-16 |g extent:12 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2013 |e 1 |c 1 |h 5-16 |g 12 | ||